课题基金 / 基金详情

Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations

Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations
用于快速、超特异性检测癌症突变的单分子动力学指纹技术的优化和验证
批准号:
10000971
负责人:
MUNEESH TEWARI
金额:
$38.84万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-13 至 2021-08-31

项目摘要

项目成果

MUNEESH TEWARI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY The ultimate vision of this proposal is to develop a technology platform for the direct, rapid, and robust detection of cancer-associated DNA mutations for diagnostics and research. DNA mutations have been known to be fundamental to cancer development for decades and specific fragments of mutated DNA have been sought as non-invasive biomarkers for cancer in blood, stool and other samples. However, a major barrier to progress has been the lack of highly sensitive, specific, and quantitative methods for detecting DNA mutation when mutant DNA fragments are present as rare alleles in a high background of wild-type DNA. We propose here an approach to DNA mutation detection and quantification that is conceptually simple, yet takes advantage of sophisticated and elegant advances in single molecule imaging science. The approach is based on using total internal reflection microscopy to detect the binding and release of a fluorescently-tagged probe to immobilized target DNA molecules on the surface of a glass slide. Differences in nucleotide sequence even at a single nucleotide, give rise to differences in the free energy of hybridization, and this affects the kinetics of binding and release of a probe in a manner that can be detected by single-molecule microscopy. We have already performed proof-of-concept and established feasibility of the approach. In this project, we aim to perform optimizations that will increase sensitivity and increase throughput, and to perform validation with clinical samples from lung cancer patients and controls.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41467-020-19673-1
发表时间: 2020-11-17
期刊: Nature communications
影响因子: 16.6
作者: [Li J, Zhang L, Johnson-Buck A, Walter NG]
通讯作者: Walter NG
DOI: 10.1016/j.ymeth.2021.06.014
发表时间: 2022-01
期刊: Methods (San Diego, Calif.)
影响因子: --
作者: [Mandal S, Khanna K, Johnson-Buck A, Walter NG]
通讯作者: Walter NG
DOI: 10.1021/acs.nanolett.2c01757
发表时间: 2022-08-10
期刊: NANO LETTERS
影响因子: 10.8
作者: [Blanchard, Aaron T., Li, Zi, Duran, Elizabeth C., Scull, Catherine E., Hoff, J. Damon, Wright, Keenan R., Pan, Victor, Walter, Nils G.]
通讯作者: Walter, Nils G.
DOI: 10.1016/j.bios.2021.113433
发表时间: 2021-10-15
期刊: Biosensors & bioelectronics
影响因子: 12.6
作者: [Khanna K, Mandal S, Blanchard AT, Tewari M, Johnson-Buck A, Walter NG]
通讯作者: Walter NG
7
    Highly specific, amplification-free, single-molecule counting of rare methylated DNA cancer biomarkers
    Clinical trial exploring the diet-microbiome axis in allo-HCT patients
    Clinical trial exploring the diet-microbiome axis in allo-HCT patients
    Clinical trial exploring the diet-microbiome axis in allo-HCT patients
    海外基金